BRIEF: Burning Rock returns to revenue growth as loss narrows
Cancer screening company Burning Rock Biotech Ltd. (BNR.US) on Wednesday reported its revenue rose 0.8% in the third quarter year-on-year to 128.6 million yuan ($17.6 million), as it returned to…
RECENT ARTICLES
-
Cash-strapped Mirxes looks for lifeline in blood-based cancer detection
-
Everest Medicines drives growth with AI-powered mRNA pipeline
1952.HK
-
After a failed Fosun buyout, what’s next for drug maker Henlius Biotech?
2696.HK
-
Yalla revenue growth returns to double-digits ahead of new gaming push
YALA.US
-
Baozun returns to the black as Gap expansion accelerates
9991.HK BZUN.US
-
Cango gets crypto jolt back to revenue growth, profitability
CANG.US
-
BRIEF: Ubtech revenue grows, loss narrows in 2024
9880.HK
